← Back to headlines
End of Apogee Drug Collaboration Leads to Revised Analyst Expectations
The conclusion of a drug collaboration for Apogee (APGE) has prompted analysts to revise their expectations for the company.
19 Feb, 00:39 — 19 Feb, 00:39
ℹOnly 1 source covers this story
